Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00117000Phase 3Unknown
Phase 3, randomised trial of testosterone undecanoate in Malnutrition (4 arms), sponsored by University of Adelaide. Primary endpoints: Days in hospital at 12 months and SF-36 quality of life scores at 12 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00117000.